Russell Investments Group, Ltd. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,026,375
-21.9%
224,279
+3.7%
0.01%
-20.0%
Q2 2023$7,711,866
+33.2%
216,261
-5.1%
0.02%
+36.4%
Q1 2023$5,788,608
-42.6%
227,898
-8.3%
0.01%
-47.6%
Q4 2022$10,083,580
+31.5%
248,609
+7.1%
0.02%
+23.5%
Q3 2022$7,671,000
+0.5%
232,145
+7.0%
0.02%
+6.2%
Q2 2022$7,634,000
-33.3%
216,867
-12.9%
0.02%
-20.0%
Q1 2022$11,445,000
-18.5%
248,907
+17.5%
0.02%
-9.1%
Q4 2021$14,047,000
+23.3%
211,923
+16.1%
0.02%
+15.8%
Q3 2021$11,395,000
-20.0%
182,538
+6.1%
0.02%
-20.8%
Q2 2021$14,243,000
+139.7%
171,991
+91.9%
0.02%
+118.2%
Q1 2021$5,942,000
-27.7%
89,642
-16.3%
0.01%
-31.2%
Q4 2020$8,215,000
+203.8%
107,058
+70.4%
0.02%
+166.7%
Q3 2020$2,704,000
-0.3%
62,8300.0%0.01%0.0%
Q2 2020$2,712,000
+270.5%
62,830
+146.4%
0.01%
+200.0%
Q1 2020$732,000
-74.5%
25,498
-43.7%
0.00%
-60.0%
Q4 2019$2,875,000
+34.5%
45,315
-40.3%
0.01%
+25.0%
Q3 2019$2,137,000
+11.2%
75,915
+5.0%
0.00%0.0%
Q2 2019$1,921,000
+99.3%
72,273
+37.5%
0.00%
+100.0%
Q1 2019$964,000
+1135.9%
52,554
+25.2%
0.00%
Q1 2017$78,00041,9870.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders